Clinical Study
Effectiveness and Safety of Concurrent Use of First-Line Antiretroviral and Antituberculous Drugs in Rwanda
Figure 1
(a) Percentage weight gain or loss observed. (b) Patients’ gain or loss in CD4 cells/mm3. (c) Physical improvement and death.